1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Clinical Trial Imaging Market- Key Findings, 2020

3. Strategic Imperatives on Global Clinical Trial Imaging Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Clinical Trial Imaging Companies

4. Clinical Trial Imaging Market Value Outlook to 2026, by Modality

• 4.1 Computed Tomography
• 4.2 Magnetic Resonance Imaging
• 4.3 Ultrasound
• 4.4 Positron Emission Tomography
• 4.5 X-Ray
• 4.6 Echocardiography
• 4.7 Other Modalities

5. Clinical Trial Imaging Market Value Outlook to 2026, by End-User

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Medical Device Manufacturers
• 5.4 Contract Research Organizations
• 5.5 Academic and Government Research Institutes
• 5.6 Other End-Users

6 Asia Pacific Clinical Trial Imaging Market Value Outlook to 2026

• 6.1 Leading Clinical Trial Imaging Types contributing to Asia Pacific market
• 6.2 Top Applications contributing to Asia Pacific Clinical Trial Imaging
• 6.3 Top countries contributing to Asia Pacific Clinical Trial Imaging

7 Europe Clinical Trial Imaging Market Value Outlook to 2026

• 7.1 Leading Clinical Trial Imaging Types contributing to Europe market
• 7.2 Top Applications contributing to Europe Clinical Trial Imaging
• 7.3 Top countries contributing to Europe Clinical Trial Imaging

8 North America Clinical Trial Imaging Market Value Outlook to 2026

• 8.1 Leading Clinical Trial Imaging Types contributing to North America market
• 8.2 Top Applications contributing to North America Clinical Trial Imaging
• 8.3 Top countries contributing to North America Clinical Trial Imaging

9 South and Central America Clinical Trial Imaging Market Value Outlook to 2026

• 9.1 Leading Clinical Trial Imaging Types contributing to South and Central America market
• 9.2 Top Applications contributing to South and Central America Clinical Trial Imaging
• 9.3 Top countries contributing to South and Central America Clinical Trial Imaging

10 Middle East Africa Clinical Trial Imaging Market Value Outlook to 2026

• 10.1 Leading Clinical Trial Imaging Types contributing to Middle East Africa market
• 10.2 Top Applications contributing to Middle East Africa Clinical Trial Imaging
• 10.3 Top countries contributing to Middle East Africa Clinical Trial Imaging

11 Business Profiles of Leading Companies

• 11.1 Business Description, SWOT and Financial Analysis of Companies in Clinical Trial Imaging market
• 11.2 Bioclinica, Inc.
• 11.3 Biomedical Systems Corporation
• 11.4 Biotelemetry, Inc.
• 11.5 Cardiovascular Imaging Technologies, LLC
• 11.6 Icon PLC
• 11.7 Intrinsic Imaging LLC
• 11.8 Ixico PLC
• 11.9 Parexel International Corporation
• 11.10 Radiant Sage LLC
• 11.11 Worldcare Clinical, LLC

12 Recent Industry Developments

13 Appendix

• 13.1 OGAnalysis Expertise
• 13.2 Sources and Methodology

The study predicts the short term and long term trends that can shape up the future of the Clinical Trial Imaging market including the COVID-19 pandemic implications for Clinical Trial Imagings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Clinical Trial Imaging market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Clinical Trial Imaging Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Clinical Trial Imaging market forecast and Clinical Trial Imaging market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Clinical Trial Imaging market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Clinical Trial Imaging industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Clinical Trial Imaging market share in developed countries.

Scope of the research-

Clinical Trial Imaging Market is analyzed and forecast over the outlook period from 2020 to 2026 By Modality
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
Positron Emission Tomography
X-Ray
Echocardiography
Other Modalities

Clinical Trial Imaging Market is analyzed and forecast over the outlook period from 2020 to 2026 by End User including
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Contract Research Organizations
Academic and Government Research Institutes
Other End-Users

Top Companies Operating in Clinical Trial Imaging market include- Bioclinica, Inc.  , Biomedical Systems Corporation  , Biotelemetry, Inc.  , Cardiovascular Imaging Technologies, LLC  , Icon PLC  , Intrinsic Imaging LLC  , Ixico PLC  , Parexel International Corporation  , 1Radiant Sage LLC  , 1Worldcare Clinical, LLC